{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:03:38Z","timestamp":1772795018179,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004702","name":"Baxter International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.thromres.2010.10.005","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T05:39:34Z","timestamp":1291095574000},"page":"S14-S17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"S1","title":["Prophylaxis in bleeding disorders"],"prefix":"10.1016","volume":"127","author":[{"given":"Johannes","family":"Oldenburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 5","key":"10.1016\/j.thromres.2010.10.005_bb0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2516.2010.02318.x","article-title":"Prophylaxis in the haemophilia population","volume":"16","author":"Blanchette","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2010.10.005_bb0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa067659","article-title":"Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia","volume":"357","author":"Manco-Johnson","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2010.10.005_bb0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2796.1994.tb00815.x","article-title":"A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs","volume":"236","author":"Aledort","year":"1994","journal-title":"J Intern Med"},{"issue":"Suppl 2","key":"10.1016\/j.thromres.2010.10.005_bb0020","first-page":"12","article-title":"Experience with prophylaxis in Germany","volume":"30","author":"Schramm","year":"1993","journal-title":"Semin Hematol"},{"key":"10.1016\/j.thromres.2010.10.005_bb0025","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0022-3476(96)70076-8","article-title":"Episodic versus prophylactic infusions for hemophilia A: a cost-effective analysis","volume":"129","author":"Smith","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.thromres.2010.10.005_bb0030","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1258\/rsmacta.43.5.528","article-title":"Association between joint bleeds and Pettersson scores in severe haemophilia","volume":"43","author":"Fischer","year":"2002","journal-title":"Acta Radiol"},{"key":"10.1016\/j.thromres.2010.10.005_bb0035","first-page":"251","article-title":"Long-term therapy and on-demand treatment of children and adolescents with severe haemophilia A: 12years of experience","volume":"22","author":"Brackmann","year":"1992","journal-title":"Haemostasis"},{"key":"10.1016\/j.thromres.2010.10.005_bb0040","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1365-2516.2001.00560.x","article-title":"Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome","volume":"7","author":"Fischer","year":"2001","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2010.10.005_bb0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2141.2005.05546.x","article-title":"Can long-term prophylaxis for severe hemophilia be stopped in adulthood? Results from Denmark and the Netherlands","volume":"130","author":"van Dijk","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2010.10.005_bb0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1538-7836.2009.03650.x","article-title":"Efficacy and safety of secondary prophylaxis vs on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month cross over study","volume":"8","author":"Collins","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.10.005_bb0055","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2516.2007.01478.x","article-title":"Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data","volume":"13","author":"Richards","year":"2007","journal-title":"Haemophilia"},{"issue":"Suppl 2","key":"10.1016\/j.thromres.2010.10.005_bb0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2516.2007.01500.x","article-title":"Prophylaxis in adults with haemophilia","volume":"13","author":"Hay","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2010.10.005_bb0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2516.2006.01189.x","article-title":"Practice patterns in haemophilia A therapy \u2013 global progress towards optimal care","volume":"12","author":"Geraghty","year":"2006","journal-title":"Haemophilia"},{"issue":"Suppl 1","key":"10.1016\/j.thromres.2010.10.005_bb0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1365-2516.9.s1.12.x","article-title":"A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres","volume":"9","author":"Blanchette","year":"2003","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2010.10.005_bb0075","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1365-2516.2008.01810.x","article-title":"The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey","volume":"14","author":"Biss","year":"2008","journal-title":"Haemophilia"},{"issue":"Suppl 2","key":"10.1016\/j.thromres.2010.10.005_bb0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-2006-946912","article-title":"Managing the pediatric patient and the adolescent\/adult transition","volume":"32","author":"Valentino","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2010.10.005_bb0085","first-page":"104","article-title":"Characterization of the pharmacokinetics of rFVIII in young pre-school children with hemophilia, including an analysis of the influence of age and body weight","author":"Blanchette","year":"2004","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"10.1016\/j.thromres.2010.10.005_bb0090","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00043426-199123000-00006","article-title":"Prophylaxis with factor concentrates in preventing hemophilic arthropathy","volume":"13","author":"Petrini","year":"1991","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.thromres.2010.10.005_bb0095","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0049-3848(09)70153-7","article-title":"The role of prophylaxis in the management of von Willebrand disease: today and tomorrow","volume":"124","author":"Abshire","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2010.10.005_bb0100","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1365-2141.2000.02507.x","article-title":"Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease","volume":"111","author":"Lak","year":"2000","journal-title":"Br J Haematol"},{"issue":"Suppl 2","key":"10.1016\/j.thromres.2010.10.005_bb0105","first-page":"S26","article-title":"Prophylaxis of bleeding episodes in patients with von Willebrand's disease","volume":"6","author":"Federici","year":"2008","journal-title":"Blood Transfus"},{"issue":"Suppl 5","key":"10.1016\/j.thromres.2010.10.005_bb0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2516.2008.01851.x","article-title":"Prophylaxis in von Willebrand disease","volume":"14","author":"Berntorp","year":"2008","journal-title":"Haemophilia"},{"issue":"Suppl 1","key":"10.1016\/j.thromres.2010.10.005_bb0115","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/01.mbc.0000167659.23262.18","article-title":"Long-term prophylaxis in von Willebrand disease","volume":"16","author":"Berntorp","year":"2005","journal-title":"Blood Coagul Fibinolysis"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384810005542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384810005542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:35:17Z","timestamp":1758735317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384810005542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":23,"alternative-id":["S0049384810005542"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2010.10.005","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylaxis in bleeding disorders","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2010.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}